Raras
Buscar doenças, sintomas, genes...
Ceratite fúngica
ORPHA:519930CID-10 · H19.2*CID-11 · 9A71DOENÇA RARA

Ceratite ou queratite é uma inflamação na córnea, a camada transparente que protege os olhos. Pode ser causada por secura, lesão física ou química, vírus, bactérias, amebas, fungos ou vermes.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Infecção da córnea causada por fungos, frequentemente associada a trauma ocular ou uso de lentes de contato. Apresenta-se com dor intensa, vermelhidão, fotofobia e visão turva, podendo levar à perda visual se não tratada precocemente.

Pesquisas ativas
2 ensaios
18 total registrados no ClinicalTrials.gov
Publicações científicas
2.140 artigos
Último publicado: 2026 Apr 17
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H19.2*
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.140PubMed
Últimos 10 anos200publicações
Pico2025154 papers
Linha do tempo
2026Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 34
2Fase 23
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 11 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ceratite fúngica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

18 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.406 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.406

#1

Diagnostic Accuracy of a CRISPR-Based Assay in Smear- and Culture-Negative Fungal Keratitis.

JAMA ophthalmology2026 Mar 05

Diagnosing fungal keratitis (FK) in patients with negative smear and culture results remains clinically challenging, highlighting the need for alternative diagnostic approaches. To determine the diagnostic accuracy of the clustered regularly interspaced short palindromic repeats (CRISPR)-based Rapid Identification of Mycoses using CRISPR (RID-MyC) assay for detecting FK in patients with negative smear and culture results using in vivo confocal microscopy (IVCM) as the reference standard. This prospective diagnostic accuracy study was conducted from December 2024 to March 2025 at Aravind Eye Hospital, a tertiary ophthalmology referral hospital in Coimbatore, India. Consecutive patients clinically suspected to have microbial keratitis with negative smear and culture results were eligible for inclusion. Data were analyzed from March 2025 to June 2025. All included participants underwent corneal scraping for RID-MyC assay and imaging by IVCM. The primary outcomes were sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic concordance of the RID-MyC assay compared with IVCM results. Of 245 consecutive patients clinically suspected to have microbial keratitis, 82 were smear negative. After exclusions due to contraindications or positive subsequent cultures, 41 patients with smear- and culture-negative results were ultimately included in the final analysis. Of these 41 patients (mean [SD] age, 51.0 [14.6] years; 21 [51.2%] women), RID-MyC demonstrated sensitivity of 82.1% (95% CI, 63%-94%) and specificity of 76.9% (95% CI, 46%-95%). Positive predictive value was 88.5% (95% CI, 74%-95%) and negative predictive value was 66.7% (95% CI, 46%-82%). Concordance between RID-MyC and IVCM was observed in 33 cases (80.5%). Notably, prior antifungal treatment was most frequent (4 of 5 [80%]) among patients with positive IVCM but negative RID-MyC results. Conversely, all patients (3 of 3 [100%]) with negative IVCM but positive RID-MyC findings had smaller, peripheral, or paracentral lesions. In this diagnostic study, in patients with smear- and culture-negative FK, the RID-MyC assay showed good diagnostic accuracy comparable with IVCM and was feasible in all cases, including those in whom imaging was not possible. With its rapid turnaround and minimal equipment needs, RID-MyC may serve as a practical adjunct to conventional diagnostics, particularly in high-burden, resource-limited settings where IVCM is unavailable or contraindicated.

#2

Detection of Endothelial Plaque in Microbial Keratitis Using Anterior Segment Optical Coherence Tomography.

medRxiv : the preprint server for health sciences2026 Feb 04

To evaluate the intra- and inter-grader concordance of anterior segment optical coherence tomography (ASOCT) grading for detection of endothelial plaque in microbial keratitis, and to compare endothelial plaque detection via ASOCT grading versus in-person slit lamp examination. Diagnostic concordance study of 150 consecutive patients with microbiologically confirmed bacterial or fungal keratitis at a high-volume tertiary eye hospital in India. Two masked ophthalmologist graders independently evaluated ASOCT images for presence of two morphologically distinct endothelial plaque subtypes noted during image review (round and flat plaques). We assessed intra-grader and inter-grader concordance for each endothelial plaque morphology and for presence of either morphology. Diagnostic agreement between ASOCT and in-person slit lamp examination was evaluated using percent agreement, Cohen's kappa, sensitivity, and specificity. Univariable and multivariable logistic regression was used to assess odds of disagreement between ASOCT and slit lamp examination for endothelial plaque detection. ASOCT detection showed near perfect inter-grader agreement for round endothelial plaques (kappa 0.88, 94.7% agreement), flat endothelial plaques (kappa 0.84, 92.0% agreement), and either plaque (kappa 0.88, 94.0% agreement). Intra-grader agreement was substantial to near perfect for both graders across all plaque types (kappa 0.70-0.86). Ophthalmologist slit lamp examination identified endothelial plaque in 6.0% eyes, while ASOCT detected round plaques in 32.7%, flat plaques in 43.3%, and either plaque in 55.3% of eyes. Using ASOCT as reference, slit lamp examination demonstrated sensitivity of 16.3% for round plaques, 6.2% for flat plaques, and 9.6% for either plaque, with specificity exceeding 94% for all. Poor visual acuity (logMAR ≥1.0) was associated with increased disagreement for round plaques (adjusted OR 5.04), flat plaques (adjusted OR 3.63), and either plaque (adjusted OR 3.98). Bacterial infection was associated with increased disagreement for any endothelial plaque (adjusted OR 4.56). Slit lamp examination substantially under-detects endothelial plaque compared to ASOCT, while ASOCT enables reproducible detection with excellent intra- and inter-grader agreement. These findings support incorporation of ASOCT imaging into microbial keratitis evaluation protocols. Differences in round and flat endothelial plaque morphologies warrant further investigation.

#3

Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates.

Investigative ophthalmology & visual science2026 Jan 05

The purpose of this study was to evaluate the in vitro effects of combining rose bengal (RB) photodynamic antimicrobial therapy (PDAT) with conventional topical antifungals (amphotericin B, natamycin, and voriconazole) on clinical Fusarium and Aspergillus isolates and to determine the antifungal stability under experimental conditions. Clinical isolates of Fusarium spp. (n = 3) and Aspergillus spp. (n = 3) were cultured using standard microbiology techniques. Agar plates were prepared with three concentrations of amphotericin B, natamycin, or voriconazole along with plates containing no antifungals. The following groups were tested in both dark and light conditions: (1) antifungal monotherapy (antifungal only), (2) RB monotherapy (RB only), and (3) antifungal and RB combination therapy. Plates were incubated for 7 days and percent growth inhibition was quantified. UV-visible spectroscopy and mass spectrometry was performed to assess antifungal stability. Overall, Fusarium isolates were more susceptible to RB-PDAT than Aspergillus isolates. RB-PDAT combination therapy with natamycin reduced growth inhibition, whereas combination therapy with voriconazole increased growth inhibition compared to antifungal monotherapy. UV-visible spectroscopy demonstrated 70% degradation of amphotericin B and full degradation of natamycin when combined with RB-PDAT, whereas voriconazole remained stable. Across both Fusarium and Aspergillus isolates, treatment responses to antifungals with or without RB-PDAT demonstrated strain-specific effects. The increased fungal inhibition and maintained stability of voriconazole when combined with RB-PDAT highlight its potential compatibility with RB-PDAT. In contrast, the reduced inhibition and degradation of natamycin and amphotericin B with RB-PDAT suggests that drug stability may be a factor to consider when integrating RB-PDAT into fungal keratitis management.

#4

Ion-activated mucoadhesive in situ gel incorporating terbinafine-loaded NLCs promotes ocular penetration and retention for enhanced fungal keratitis therapy.

Materials today. Bio2026 Apr

Fungal keratitis (FK) is a sight-threatening infection with poor outcomes due to rapid tear clearance and insufficient corneal penetration. To overcome the limitations, we developed an ion-activated mucoadhesive in-situ gelling system (TH-NLC-ISG) integrating terbinafine-loaded nanostructured lipid carrier (TH-NLC) into a gellan gum/carboxymethyl chitosan matrix. The optimized formulation exhibited a particle size of 25.27 ± 0.75 nm. Upon contact with simulated tear fluid, the formulation underwent rapid sol-gel transition, achieving a 70-fold viscosity increase (34 °C, shear rate 1 s-1), critical for prolonged ocular residence. Fluorescence imaging demonstrated ocular retention of fluorescein sodium-labeled TH-NLC-ISG exceeding 60 min, significantly longer than the non-gelling control. In vivo pharmacokinetic studies revealed markedly improved ocular bioavailability, with higher area under the concentration in ocular tissues-time curve of TH in the TH-NLC-ISG group compared to TH-NLC. Corneal penetration studies confirmed that TH-NLC-ISG exhibited longer corneal retention time and higher corneal drug retention compared to TH-NLC. The formulation demonstrated excellent ocular biocompatibility in vitro and in vivo. TH-NLC-ISG exhibited potent in vitro antifungal activity against Fusarium solani. and Aspergillus flavus., with a lower MIC50 value than TH suspension. In rabbits and mice FK models, TH-NLC-ISG group achieved complete corneal healing, reduced clinical scores and corneal perforation rates, displaying efficacy superior to conventional natamycin eye drops. By synergistically augmenting retention and corneal permeation, TH-NLC-ISG provides a transformative strategy for enhanced fungal keratitis therapy.

#5

Severe fungal keratitis caused by Lasiodiplodia theobromae following grass trimmer-related ocular trauma: a case report.

Medical mycology case reports2026 Jun

Lasiodiplodia theobromae is an uncommon but emerging filamentous fungus primarily recognized as a plant pathogen. We report a case of severe L. theobromae keratitis in a 57-year-old man who presented with left eye pain, redness, and progressive visual loss following grass trimmer-related ocular trauma. Ocular examination revealed diffuse corneal haziness, dense stromal infiltrate, total epithelial defect, and descemetoceles. The organism was isolated from corneal scrapings and identified by microscopy, culture, MALDI-TOF mass spectrometry, and confirmatory ITS sequencing. Management required intensive topical, intravitreal, and systemic antifungal therapy in addition to surgical intervention. Visual acuity remained at light perception at three weeks postoperatively, with no further deterioration observed following combined surgical and medical management. Early diagnosis remains challenging due to overlapping morphological features with other filamentous fungi, necessitating molecular confirmation.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.011 artigos no totalmostrando 197

2026

Ion-activated mucoadhesive in situ gel incorporating terbinafine-loaded NLCs promotes ocular penetration and retention for enhanced fungal keratitis therapy.

Materials today. Bio
2026

Severe fungal keratitis caused by Lasiodiplodia theobromae following grass trimmer-related ocular trauma: a case report.

Medical mycology case reports
2026

Therapeutic Penetrating Keratoplasty for Aspergillus Fungal Keratitis: A Case Report.

Cureus
2026

Climate's eye: A 20-year study on climate and pollution impacts on fungal keratitis incidence.

Journal of infection and public health
2025

Overcoming corneal barriers: Posaconazole loaded cationic surfactant vesicles for enhanced ocular permeability and anti-fungal efficacy.

Asian journal of pharmaceutical sciences
2026

Bacterial and fungal keratitis in Northeast Mexico: demographic, predisposing, and microbiological differences among non-contact lens, optical contact lens, and bandage contact lens wearers.

International ophthalmology
2026

Diagnostic Accuracy of a CRISPR-Based Assay in Smear- and Culture-Negative Fungal Keratitis.

JAMA ophthalmology
2026

Corneal transcriptomic signatures of mycotoxin exposure reveal distinct immune and metabolic responses.

Ecotoxicology and environmental safety
2026

Bridging Gaps in Fungal Keratitis Management: Novel Diagnostics, Drug Delivery Systems, and Gene Therapies.

AAPS PharmSciTech
2026

Beyond the Hospital - Bacterial and Fungal Keratitis in Private Ophthalmic Care.

Klinische Monatsblatter fur Augenheilkunde
2026

Dual Ferroptosis-Inhibitory and Antifungal Therapy for Fungal Keratitis Using a Defect-Adhesive Thermoresponsive Hydrogel.

Advanced healthcare materials
2026

Purpureocillium lilacinum Keratitis Outbreak Associated with an Ophthalmology Clinic - New York City, 2024.

MMWR. Morbidity and mortality weekly report
2026

Letter Regarding: Temporary Conjunctival Flap Plus Medical Treatment Versus Medical Treatment Only for High-Risk Fungal Keratitis: A Randomized Controlled Trial.

Cornea
2026

Isoimperatorin alleviates fungal keratitis by regulating NF-κB pathway and macrophage immune response.

Frontiers in immunology
2026

Detection of Endothelial Plaque in Microbial Keratitis Using Anterior Segment Optical Coherence Tomography.

medRxiv : the preprint server for health sciences
2026

A neutrophil membrane-biomimetic drug delivery system enhances the antifungal and anti-inflammatory efficacy of natamycin for fungal keratitis.

Biomaterials advances
2026

Zinc peroxide-copper bimetallic nanozyme with self-activated ROS and cuproptosis for superficial antifungal therapy.

Journal of nanobiotechnology
2026

[Advances in clinical diagnosis and treatment of pythium keratitis].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2026

Efficacy and Safety of Intracameral Amphotericin B for Fungal Keratitis: A Systematic Review and Meta-Analysis.

International journal of antimicrobial agents
2026

Natamycin in Food and Ophthalmology: Knowledge Gaps and Emerging Insights from Zebrafish Models.

Pharmaceuticals (Basel, Switzerland)
2026

Current Challenges and Long-Term Outcomes in Corneal Transplantation in Infectious Keratitis-A Systematic Review.

Journal of clinical medicine
2026

Fungal keratitis in Germany : Diagnostics, conservative and microsurgical treatment.

Die Ophthalmologie
2026

IL-24 regulates corneal inflammation and fibrosis in fungal keratitis via the caspase-11/gasdermin D pathway.

The ocular surface
2026

Sennoside A alleviates fungal keratitis by modulating inflammation and immune responses through the caspase-1/GSDMD pathway.

Cytokine
2026

Fungal keratitis following laser assisted lenticule extraction surgery with use of losartan as an anti-scarring agent - a case report.

American journal of ophthalmology case reports
2026

Clinical Characteristics and Outcomes of Rare Fungal Keratitis Caused by Plectosphaerella cucumerina: A Retrospective Case Series Analysis.

Mycopathologia
2026

Adjunctive tacrolimus in the treatment of fungal keratitis requiring therapeutic penetrating keratoplasty.

American journal of ophthalmology case reports
2026

Duplex droplet digital PCR (ddPCR) improves the diagnosis of Aspergillus and Fusarium keratitis.

Experimental eye research
2026

Eyes on the future: PVA-hydrogel lenses as a platform for amphotericin B ocular delivery.

International journal of pharmaceutics
2025

Purpureocillium lilacinum Keratitis and Endophthalmitis in an Aphakic Eye With Secondary Glaucoma: A Case Report.

Cureus
2026

TLR9-mediated activation of the NLRP3 inflammasome in Fusarium solani-induced keratitis.

Experimental eye research
2026

Efficacy of 0.5% Voriconazole Subpalpebral Lavage as Adjunctive Therapy: A Multicenter Prospective Study in Fungal Keratitis Management.

Ocular immunology and inflammation
2026

Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates.

Investigative ophthalmology & visual science
2025

Pediatric Fungal Keratitis: Predisposing Factors, Clinical Features, and Outcomes During a 24-Year Study.

Translational vision science & technology
2026

Green Light-Activated Rose Bengal Cross-Linking in 81 Horses With Complex Corneal Ulcers and Stromal Abscesses.

Veterinary ophthalmology
2025

Argon Laser Phototherapy as an Adjunctive Treatment for Refractory Fungal Keratitis: A Retrospective Case Series.

Cureus
2025

Lipoic Acid Modulates Nrf2/HO-1 Pathway to Suppress Inflammation in Fungal Keratitis Through Host-Directed Cytoprotective Mechanisms.

Journal of visualized experiments : JoVE
2025

Renaissance of an Emerging Pathogen-Pythium insidiosum Keratitis: An Indian Perspective.

Clinical ophthalmology (Auckland, N.Z.)
2025

Immune Camouflage in Pythium insidiosum Keratitis: A Hypothesis on Molecular Mimicry and Host Pattern Recognition Receptor Evasion.

Clinical ophthalmology (Auckland, N.Z.)
2025

Recovery and regeneration: exploring positive sequelae of keratitis.

BMC ophthalmology
2025

Ocular cationic nanocarrier-based delivery of posaconazole.

Annales pharmaceutiques francaises
2025

Unveiling rare fungal pathogens: clinical insights and molecular identification in fungal keratitis cases.

International ophthalmology
2025

Ensemble Machine Learning Approaches for Automated Fungal Keratitis Diagnosis Using In Vivo Confocal Microscopy Images.

Healthcare technology letters
2025

PFKFB3 alleviates the advancement of Fusarium solani keratitis by attenuating macrophage inflammation.

Frontiers in cellular and infection microbiology
2026

Caspofungin-loaded dissolving microneedles for transcorneal delivery in fungal keratitis.

Experimental eye research
2025

Impact of biofilm formation in fungal corneal ulcers on treatment outcomes: a systematic review and meta-analysis.

Journal of medical microbiology
2025

MoS2-x/C Nanosheets for Antifungal and Anti-Inflammatory Therapy of Aspergillus fumigatus Keratitis in Mice.

International journal of nanomedicine
2025

An Interesting Case of Ocular Nocardiosis Mistaken as a Fungal Corneal Ulcer.

Cureus
2025

Ex Vivo Goat Corneal Model for Investigating Host Immune Responses and Antifungal Drug Testing in Fusarium Keratitis.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
2025

Distinguishing Fungal Keratitis from HSV Endothelial Keratitis: A Comparative Clinical and Diagnostic Analysis.

Seminars in ophthalmology
2025

Clinical Outcomes of Rose Bengal Photodynamic Therapy for Severe Infectious Keratitis.

Cornea
2025

Comparing Microbiologic Tests for Pathogen Detection in Infectious Keratitis Using Latent Class Analysis.

Cornea
2026

Cu-Single Atoms/Clusters-Nanoenzymes Trigger and Integrate Tandem Effect to Synchronously Boost Antifungal and Anti-Inflammation for Fungal Keratitis.

Advanced healthcare materials
2025

Efficacy of natamycin monotherapy versus combination therapy with voriconazole for fungal keratitis: a randomised clinical trial.

The British journal of ophthalmology
2026

Voriconazole nanosuspension-loaded ocular bilayer dissolving microneedle patch for the management of fungal keratitis.

Drug delivery and translational research
2026

Antimicrobial Blue Light for Treatment of Candida albicans Keratitis: Efficacy in Ex Vivo Rabbit Corneas and Safety Evaluation in Retinal Cells In Vitro.

Lasers in surgery and medicine
2025

First report of rare fungal keratitis: Diaporthe aspalathi.

BMC ophthalmology
2026

First Reported Case of Fungal Keratitis Caused by Vishniacozyma victoriae.

Klinische Monatsblatter fur Augenheilkunde
2026

Baicalin ameliorates Aspergillus fumigatus keratitis by its antifungal activity and suppression of pyroptosis.

International immunopharmacology
2026

Vitamin C enhances corneal fungal infection treatment in mice via chemotaxis and anti-inflammation.

Antimicrobial agents and chemotherapy
2025

In Vivo Confocal Microscopy and Anterior Segment Optical Coherence Tomography in Optimizing Diagnosis and Therapeutic Management in Fungal Keratitis: Case Reports and Literature Review.

Journal of clinical medicine
2025

Clinical profile and outcomes of dematiaceous fungal keratitis - data from a secondary center in rural North India.

Journal of ophthalmic inflammation and infection
2025

A Rare Case of Alternaria citri Keratitis Successfully Treated with Voriconazole.

Journal of fungi (Basel, Switzerland)
2025

Beauveria bassiana keratitis - the first Hungarian case report.

BMC ophthalmology
2025

Fungal keratitis: Does antifungal Resistance Influence the outcome?

International ophthalmology
2025

Unusual presentation of fungal keratitis and endogenous endophthalmitis in Sézary syndrome: a case report.

American journal of ophthalmology case reports
2025

A review of technological advances in the management of bacterial, fungal, viral, and Acanthamoeba keratitis.

Clinical & experimental optometry
2026

Dysbiosis of bacterial and fungal microbiomes affects the disease process and treatment outcome in fungal keratitis.

Experimental eye research
2025

Clinical features, microbiological characteristics, and treatment outcomes of fungal keratitis in a tertiary referral hospital in Eastern China.

BMC infectious diseases
2026

Sanguinarine attenuates Aspergillus fumigatus keratitis by exerting antifungal and anti-inflammatory effects.

Experimental eye research
2025

Corneal retention using a nanorobot-based eyedrop.

Journal of materials chemistry. B
2025

Comparative efficacy and safety of topical caspofungin 0.5% and voriconazole 1% for fungal keratitis: a pilot clinical trial.

Scientific reports
2025

A 3D Fusarium keratitis model reveals isolate-specific adhesion and invasion properties in the Fusarium solani species complex.

mSphere
2025

Infectious Keratitis: A Tertiary Center's Approach to Diagnosis, Management, and Enhanced Outcomes Through Microbiological Analysis.

Microorganisms
2025

Advancing diagnostics in Pythium insidiosum keratitis: the emerging role of point-of-care imaging and biosensor-based detection devices.

Expert review of medical devices
2025

A Case Report and Global Perspective on Fusarium Superficial Keratitis in the Pediatric Population.

Cureus
2025

Fungal Keratitis Caused by Alternaria alternata: A Rare Pathogen and Its Surgical Treatment.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
2025

Fusarium Corneal Abscess: A Case Report.

Cureus
2025

Molecular characterization and antifungal susceptibility profile of Podospora bulbillosa keratitis: case series and review of literature.

Journal de mycologie medicale
2025

Fusarium solani Activates PANoptosis and Modulates Immune Response in Fungal Keratitis.

Investigative ophthalmology & visual science
2025

A Rare Case of Pseudomonas aeruginosa Keratoscleritis: Highlighting Early Diagnosis and Aggressive Treatment.

Cureus
2025

Not All Fungi and Games: An Unusual Case of Fungal Keratitis in Michigan.

Cureus
2025

Rosemary Essential Oil Microemulsion for Fungal Keratitis Treatment.

Chemistry & biodiversity
2025

Design and Evaluation of Econazole-Loaded Nanostructured Lipid Carriers for Ocular Treatment of Fungal Keratitis: In vitro and Ex vivo Studies.

Pharmaceutical nanotechnology
2025

Trypan blue staining for fungal keratitis diagnosis: a comparative study in rural India.

International ophthalmology
2025

Medical interventions for fungal keratitis.

The Cochrane database of systematic reviews
2025

Culture positivity of anterior chamber exudate in cases of fungal keratitis.

International ophthalmology
2025

Nigrospora oryzae keratitis: a rare fungal etiology.

International ophthalmology
2025

In Vitro Antifungal Activity of Amphotericin B-Encapsulated Silk Fibroin-Chitosan Nanoparticles Against Fusarium solani Isolates from Keratitis Patients.

Pharmaceutics
2025

Predictors of vision-related quality of life in patients treated for filamentous fungal keratitis.

The ocular surface
2025

Localized Versus Diffuse Corneal Invasion in Fungal Keratitis: Histological Insights from Candida albicans and Fusarium falciforme.

Journal of fungi (Basel, Switzerland)
2025

Scedosporium apiospermum and Lomentospora prolificans emergent ocular infections in North India.

Indian journal of ophthalmology
2025

Achaetomium luteum and Exserohilum rostratum, Two Rare Causes of Keratomycosis in China: Case Report.

Infection and drug resistance
2025

Correlation between corneal concentration and minimum inhibitory concentration of antifungals in patients undergoing therapeutic keratoplasty for fungal keratitis.

Indian journal of ophthalmology
2025

Structure-Activity Relationship in ε-Lysine Peptides: The Length Effects on Antifungal Activity.

Biomacromolecules
2025

SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections.

The Journal of biological chemistry
2025

Pre-Colonization of Bacillus siamensis on Ocular Surface Mitigates Fusarium keratitis Through Direct Antifungal Activity and Pre-Activation of NF-κB Pathway.

Investigative ophthalmology & visual science
2025

Fungal keratitis caused by Pyrenochaeta unguis-hominis: Identification and microbiological characteristics of a rare case.

IDCases
2025

Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy.

Mycopathologia
2025

First Isolation of a Multi-azole-Resistant Aspergillus fumigatus cyp51A TR46/Y46F/F70L Mutant in a Patient with Fungal Keratitis.

Mycopathologia
2025

Prospective study on combined use of Sabouraud dextrose agar and blood agar for improved recovery of etiological agents in mycotic and Pythium keratitis.

Journal of microbiological methods
2025

Aspergillus flavus Keratitis After Penetrating Keratoplasty.

Cureus
2025

The IL-36γ/PEDF/PPARγ signalling pathway plays an anti-inflammatory role in Candida albicans keratitis.

Scientific reports
2025

Management of microbial keratitis by private pharmacies in Uganda: a study of knowledge, attitude, and practice.

Wellcome open research
2025

Corrigendum to "New Biomarkers for Patients With Fungal Keratitis From Blood Routine Examination: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio".

Journal of ophthalmology
2025

A case of rare fungal keratitis caused by Pseudoshiraia conidialis.

Medicine
2025

Self-assembled nanopeptide dendrites with high antifungal activity and protease hydrolytic stability for fungal keratitis treatment.

Journal of nanobiotechnology
2025

Clinical recommendations for the management of Pythium insidiosum keratitis.

The ocular surface
2025

Healing efficiency of nystatin-loaded chitosan-guar gum-based nanocapsules in experimental fungal keratitis.

International journal of biological macromolecules
2025

Detection of Fusarium solani using cutinase antibody and its application in diagnosing fungal keratitis in an animal model.

PloS one
2025

Diagnostic Accuracy of Clinic-Based Loop-Mediated Isothermal Amplification and Quantitative PCR for Fungal and Acanthamoeba Keratitis.

Cornea
2025

Reactive oxygen species mediate black phosphorus quantum dots assembled microneedle patches for keratitis therapy.

Journal of controlled release : official journal of the Controlled Release Society
2025

Multilayered fresh amniotic membrane transplantation in resistant fungal corneal ulceration.

Medical hypothesis, discovery & innovation ophthalmology journal
2025

The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis.

Frontiers in medicine
2025

Shikonin treats Aspergillus fumigatus keratitis by activating autophagy and reducing fungal load.

Experimental eye research
2025

Artesunate Treats Aspergillus fumigatus Keratitis by Inhibiting Fungal Activity and Activating Autophagy Pathway to Reduce Corneal Inflammation.

Investigative ophthalmology & visual science
2025

[Pay attention to keratoconjunctivitis caused by microsporidia infection].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2025

Adjunctive Topical Calcineurin Inhibitors During the Treatment of Fungal Keratitis: Practice Patterns and Opinions.

Cornea
2025

Deep learning-based classification of fungal and Acanthamoeba keratitis using confocal microscopy.

The ocular surface
2025

Development of reactive oxygen species-sensitive polyethylene glycol-modified voriconazole-loaded nanomicelles for treating fungal keratitis.

Colloids and surfaces. B, Biointerfaces
2026

Boronic acid derivatives inhibit Candida albicans growth by compromising energy metabolism.

Journal of advanced research
2025

Cutaneous mucormycosis: Unveiling rare manifestations.

Journal of family medicine and primary care
2025

Rapid one-tube RPA-coupled CRISPR/Cas12a-based RID-MyC assay for the diagnosis of fungal keratitis.

Indian journal of ophthalmology
2025

Fungal keratitis: slow, relentless, and breaching.

Eye (London, England)
2025

Unveiling purine metabolism targets in the pathogenesis of fungal Keratitis: A combined proteomics and metabolomics approach.

Experimental eye research
2025

[Fungal keratitis in Germany : Diagnostics, conservative and microsurgical treatment].

Die Ophthalmologie
2025

Nanomedicine in fungal keratitis: current applications and future prospects.

Frontiers in microbiology
2025

Pyrenochaeta unguis-hominis-associated fungal keratitis: A rare case report with in vivo confocal microscopy findings.

American journal of ophthalmology case reports
2025

Outcomes of anterior chamber wash with adjuvant intracameral and intrastromal voriconazole in deep stromal fungal keratitis with endoexudates - A retrospective study.

Indian journal of ophthalmology
2025

The protective mechanisms of glycyrrhizic acid for deoxynivalenol-induced toxicity in rabbit corneal stroma.

Toxicology in vitro : an international journal published in association with BIBRA
2025

Climate Change and the Impact on Ocular Infectious Diseases: A Narrative Review.

Ophthalmology and therapy
2025

Emerging ocular pathogen: multidrug-resistant Corynespora cassiicola in fungal keratitis: case series and literature review.

International ophthalmology
2025

Evaluation of the potential for diagnosis of fungal keratitis using a Fusarium-specific antibody.

Scientific reports
2025

Optimal infiltration depth threshold for low-temperature plasma ablation in fungal keratitis.

Journal of ophthalmic inflammation and infection
2025

Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis.

Indian journal of ophthalmology
2025

Nonresponding fungal keratitis: Hope with intrastromal injections.

Indian journal of ophthalmology
2025

Purpureocillium lilacinum keratitis in a methamphetamine user: Case report.

Taiwan journal of ophthalmology
2025

Fabrication of nanozyme thixotropic anionic hydrogel for treating fungal keratitis by Dectin-1/p38 pathway.

Applied microbiology and biotechnology
2025

Targeting fungal keratitis: In vivo efficacy of corneal-targeting and non-targeting peptides againstFusarium dimerum.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2025

ZIF-8-coated ZnO with pH-responsive natamycin release boosting the antifungal and anti-inflammation activity to treat fungal keratitis.

Journal of materials chemistry. B
2025

Exosomal let-7b-5p derived from Aspergillus fumigatus-treated human corneal epithelial cells promotes M1 macrophage activation via targeting SOCS-1.

Frontiers in immunology
2025

Pyroptosis Mediated by ROS/Caspase-3/GSDME Pathway in Aspergillus fumigatus-Induced Fungal Keratitis.

Investigative ophthalmology & visual science
2025

Fungal Keratitis following the Application of Green Tea Bag Warm Compresses.

Case reports in ophthalmology
2025

Fusarium spp. and Aspergillus flavus infection induces pathogen-specific and pathogen-independent host immune response in patients with fungal keratitis.

Frontiers in cellular and infection microbiology
2025

Randomised controlled trial of topical combination therapy chlorhexidine 0.2% and natamycin 5% versus topical natamycin 5% alone for fungal keratitis in East Africa: study protocol.

Wellcome open research
2025

Moderation of cross linkage of sodium alginate-polyethylene oxide films loaded with natamycin for treatment of Aspergillus fumigatus keratitis.

Journal of materials science. Materials in medicine
2025

Rose Bengal-Assisted Photodynamic Antimicrobial Therapy for Keratitis.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
2025

Deep Fungal Stromal Keratitis After Cataract Surgery: A Case Report.

Cureus
2025

Alterations in ocular fungal microbiota in patients with fungal keratitis: a comparative study from coastal regions of Eastern China.

BMC ophthalmology
2025

First report of Stemphylium lycopersici keratitis, a complex corneal infection case.

Journal of ophthalmic inflammation and infection
2025

Itraconazole Loaded Micelle Based on Methoxy Poly(Ethylene Glycol)-Poly(D, L-Lactic Acid) for Ocular Drug Delivery: In vitro and in vivo Evaluation.

International journal of nanomedicine
2025

Clinical and microbiological profile of patients with fungal keratitis demonstrating unusual yeast-like structures in potassium hydroxide with calcofluor white preparation of corneal scraping.

Journal of ophthalmic inflammation and infection
2025

Retrospective Review of Fungal Keratitis at Two Tertiary Hospitals in Perth, Western Australia Between 2006 and 2022.

Mycoses
2025

Exogenous Fungal Endophthalmitis: A 20-Year Experience at a Tertiary Referral Centre in North China.

Ocular immunology and inflammation
2025

Advancing fungal keratitis treatment: transitioning from conventional amphotericin B therapy to nanocarrier-based delivery systems.

Naunyn-Schmiedeberg's archives of pharmacology
2025

Propranolol is efficacious against Aspergillus and Fusarium corneal isolates in vitro and in a murine model of Aspergillus keratitis.

Antimicrobial agents and chemotherapy
2025

Chitosan-Based Intelligent Microneedles for Delivery of Amphotericin B Loaded Oleosomes: Antifungal Ocular Patch Targeting for Effective Against Fungal Keratitis Using Rabbit Model via TLR4/NLRP3 Pathway.

International journal of nanomedicine
2025

Pathology-inspired collagen-binding thermosensitive micelle drops enable prolonged and efficient treatment of fungal keratitis.

Bioactive materials
2025

A Rare Case of Keratitis Caused by Graphium basitruncatum in China.

Infection and drug resistance
2025

Evolving indications and surgical trends in keratoplasty: a 7-year analysis from a Chinese tertiary referral center.

International ophthalmology
2025

Fungal Keratitis Caused by Scedosporium apiospermum in an Immunocompetent Patient: How Challenging Can Treatment get?

The new microbiologica
2025

Enhanced Detection of Bacterial Ocular Pathogens: A Comparative Study of Broad-Range Real-Time PCR and Conventional Culture Methods.

Diagnostics (Basel, Switzerland)
2025

Antifungal susceptibility and clinical efficacy of chlorhexidine combined with topical ophthalmic medications against Fusarium species isolated from corneal samples.

Frontiers in cellular and infection microbiology
2025

Therapeutic Efficacy of Ultraviolet C Light on Fungal Keratitis-In Vitro and Ex Vivo Studies.

Antibiotics (Basel, Switzerland)
2025

Corneal cross-linking for infectious keratitis of various causes: an umbrella review.

BMC ophthalmology
2025

Zeolitic Imidazolate Framework-90 Treats Fungal Keratitis by Promoting Macrophage Apoptosis and Targeting Increased Mitochondrial Reactive Oxygen Species in Aspergillus Fumigatus.

International journal of nanomedicine
2025

Alternative photosensitizer penetration depth evaluation in ex vivo human eyes for photodynamic antimicrobial therapy.

Therapeutic delivery
2025

A case of corneal infection with Clonostachys rosea.

BMC infectious diseases
2025

Bifunctional chemokine-nanobody fusion protein enhances neutrophil recruitment to impede Acanthamoeba immune evasion.

EBioMedicine
2025

Keratomycosis: An insight into epidemiology, etiology, and antifungal susceptibility testing of causative agents at a tertiary care centre.

Medical mycology
2025

Corneal rupture in a 19-year-old Quarter Horse mare.

Journal of the American Veterinary Medical Association
2025

Predicting the causative agent in microbial keratitis: the role of anterior segment optical coherence tomography-a cross-sectional analysis.

International ophthalmology
2025

Minimally invasive treatment of fungal keratitis with voriconazole microneedle corneal patch.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
2025

Enhancing ocular drug delivery: development and in vivo evaluation of mucoadhesive nanostructured lipid carriers for terbinafine.

Pharmaceutical development and technology
2025

An Emerging Global Threat of Mycotic Keratitis Caused by Uncommon Fungal Species: A Systematic Review and Meta-Analysis.

Translational vision science & technology
2025

Investigating the susceptibility profiles and in vitro combinations of caspofungin, itraconazole, fluconazole, voriconazole, clotrimazole, and amphotericin B against clinical isolates causing fungal keratitis.

Diagnostic microbiology and infectious disease
2025

New Biomarkers for Patients With Fungal Keratitis From Blood Routine Examination: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.

Journal of ophthalmology
2025

Crystalline Lens Extrusion Secondary to Fungal Keratitis.

Balkan medical journal
2025

Deep learning by Vision Transformer to classify bacterial and fungal keratitis using different types of anterior segment images.

Computers in biology and medicine
2025

Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation.

International journal of pharmaceutics: X
2025

The therapeutic effect and mechanism of carnosic acid in Aspergillus fumigatus keratitis.

Experimental eye research
2025

A masked study to differentiate in vivo confocal microscopic features of Pythium insidiosum and fungal filaments.

The ocular surface
2025

Evisceration as an Alternative to Enucleation in Four Pet Psittacine Birds.

Journal of avian medicine and surgery
2025

Long Non-Coding RNA Osr2 Promotes Fusarium solani Keratitis Inflammation via the miR-30a-3p/ Xcr1 Axis.

Investigative ophthalmology & visual science
2025

Clinical Characteristics and Treatment Outcomes of Pediatric Fungal Keratitis.

Infection and drug resistance
2025

Phosphoglycerate mutase and methionine synthase act as adhesins of Candida albicans to the corneal epithelium, altering their expression during the tissue adhesion process.

Experimental eye research
2025

Rutin resists Aspergillus fumigatus keratitis by activating Nrf2/HO-1 pathway, inhibiting Dectin-1/p-Syk pathway and affecting fungal structures.

Experimental eye research
2025

Recent in vitro advances in the ocular antimicrobial agents against Acanthamoeba.

International journal for parasitology. Drugs and drug resistance
2026

Ultraviolet C (UV-C) Light Therapy for Equine Ulcerative Keratomycosis-An In Vitro Study.

Veterinary ophthalmology
2025

SAA1 as a key mediator of immune inflammatory pathways in fungal keratitis through FOXO3a phosphorylation regulation.

Cytokine
2025

Platelet membrane-camouflaged PLGA loaded natamycin improve the prognosis of fungal keratitis.

Biomaterials advances
2025

Piperine inhibits fungal growth and protects against pyroptosis in Aspergillus fumigatus keratitis by regulating the mTOR/HIF-1α pathway.

International immunopharmacology
2025

kexB Gene Correlates With Aspergillus flavus Keratitis Severity: A Whole-Genome Analysis.

Investigative ophthalmology & visual science
2025

Diagnosis of microbial keratitis using smartphone-captured images; a deep-learning model.

Journal of ophthalmic inflammation and infection
2026

Outcomes of a Tenon Patch Graft for Corneal Perforations in Resolving Infectious Keratitis.

Cornea
2025

Comparative analysis of the therapeutic efficacy of low-temperature plasma ablation in treating fungal keratitis caused by various strains.

International ophthalmology
2025

Hydroxytyrosol downregulates inflammatory responses via Nrf2/HO-1 axis during fungal keratitis and exerts antifungal effects.

International immunopharmacology
Ver todos os 1.011 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ceratite fúngica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Ceratite fúngica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Diagnostic Accuracy of a CRISPR-Based Assay in Smear- and Culture-Negative Fungal Keratitis.
    JAMA ophthalmology· 2026· PMID 41784973mais citado
  2. Detection of Endothelial Plaque in Microbial Keratitis Using Anterior Segment Optical Coherence Tomography.
    medRxiv : the preprint server for health sciences· 2026· PMID 41674599mais citado
  3. Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates.
    Investigative ophthalmology & visual science· 2026· PMID 41533911mais citado
  4. Ion-activated mucoadhesive in situ gel incorporating terbinafine-loaded NLCs promotes ocular penetration and retention for enhanced fungal keratitis therapy.
    Materials today. Bio· 2026· PMID 41867499mais citado
  5. Severe fungal keratitis caused by Lasiodiplodia theobromae following grass trimmer-related ocular trauma: a case report.
    Medical mycology case reports· 2026· PMID 41859006mais citado
  6. Successful Medical Management of Pigmented Fungal Keratitis Following Vegetative Trauma.
    Ann Afr Med· 2026· PMID 41992415recente
  7. Farrerol mitigates fungal keratitis by enhancing fungal clearance and limiting inflammation through autophagy and Nrf2 pathway.
    Phytomedicine· 2026· PMID 41990530recente
  8. Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In-Vitro Characterization & In-Vivo Pharmacokinetic Assessment.
    Biopharm Drug Dispos· 2026· PMID 41989093recente
  9. Electrostatic-tailored Leciplex system of ketoconazole for boosted ocular pharmacology and cytotoxicity assessment.
    Naunyn Schmiedebergs Arch Pharmacol· 2026· PMID 41984192recente
  10. Corneal Targeted Mucoadhesive Emulsion for Prolonged Delivery of Voriconazole: Formulation Evaluation and Pharmacokinetic Assessment.
    Biopharm Drug Dispos· 2026· PMID 41965130recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:519930(Orphanet)
  2. MONDO:0033821(MONDO)
  3. GARD:22134(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Ceratite fúngica
Compêndio · Raras BR

Ceratite fúngica

ORPHA:519930 · MONDO:0033821
CID-10
H19.2* · Transtorno da esclerótica e da córnea em doenças classificadas em outra parte
CID-11
Ensaios
2 ativos
MedGen
UMLS
C1262117
EuropePMC
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades